 | • レポートコード：QFJ1-4400 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、関節疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、リハビリテーション、外科手術）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・関節疾患治療薬の市場動向 ・企業の競争状況、市場シェア ・関節疾患治療薬の種類別市場規模と予測2016-2027（薬物療法、リハビリテーション、外科手術） ・関節疾患治療薬の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・関節疾患治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・関節疾患治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・関節疾患治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・関節疾患治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・関節疾患治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Pfizer、Bristol-Myers Squibb、Roche、GlaxoSmithKline、AstraZeneca、Astellas Pharma、Johnson&Johnson、Amgen、Novartis、Sanofi、Daiiachi Sankyo） ・結論 |
Joint disease is defined as any type of injury or inflammation or disease that affects the joints of the body. Joint disease can range from acute to very chronic, excruciatingly painful or simply nagging and uncomfortable.
Market Analysis and Insights: Global Joint Disease Therapeutics Market
The global Joint Disease Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Joint Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Joint Disease Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Joint Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Joint Disease Therapeutics market.
Global Joint Disease Therapeutics Scope and Market Size
Joint Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Joint Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Drug Therapy
Rehabilitation
Surgical Operation
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie
Pfizer
Bristol-Myers Squibb
Roche
GlaxoSmithKline
AstraZeneca
Astellas Pharma
Johnson&Johnson
Amgen
Novartis
Sanofi
Daiiachi Sankyo
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Joint Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Therapy
1.2.3 Rehabilitation
1.2.4 Surgical Operation
1.3 Market by Application
1.3.1 Global Joint Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Joint Disease Therapeutics Market Perspective (2016-2027)
2.2 Joint Disease Therapeutics Growth Trends by Regions
2.2.1 Joint Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Joint Disease Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Joint Disease Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Joint Disease Therapeutics Industry Dynamic
2.3.1 Joint Disease Therapeutics Market Trends
2.3.2 Joint Disease Therapeutics Market Drivers
2.3.3 Joint Disease Therapeutics Market Challenges
2.3.4 Joint Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Joint Disease Therapeutics Players by Revenue
3.1.1 Global Top Joint Disease Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Joint Disease Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Joint Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Joint Disease Therapeutics Revenue
3.4 Global Joint Disease Therapeutics Market Concentration Ratio
3.4.1 Global Joint Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Joint Disease Therapeutics Revenue in 2020
3.5 Joint Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Joint Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Joint Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Joint Disease Therapeutics Breakdown Data by Type
4.1 Global Joint Disease Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Joint Disease Therapeutics Forecasted Market Size by Type (2022-2027)
5 Joint Disease Therapeutics Breakdown Data by Application
5.1 Global Joint Disease Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Joint Disease Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Joint Disease Therapeutics Market Size (2016-2027)
6.2 North America Joint Disease Therapeutics Market Size by Type
6.2.1 North America Joint Disease Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Joint Disease Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Joint Disease Therapeutics Market Size by Type (2016-2027)
6.3 North America Joint Disease Therapeutics Market Size by Application
6.3.1 North America Joint Disease Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Joint Disease Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Joint Disease Therapeutics Market Size by Application (2016-2027)
6.4 North America Joint Disease Therapeutics Market Size by Country
6.4.1 North America Joint Disease Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Joint Disease Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Joint Disease Therapeutics Market Size (2016-2027)
7.2 Europe Joint Disease Therapeutics Market Size by Type
7.2.1 Europe Joint Disease Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Joint Disease Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Joint Disease Therapeutics Market Size by Type (2016-2027)
7.3 Europe Joint Disease Therapeutics Market Size by Application
7.3.1 Europe Joint Disease Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Joint Disease Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Joint Disease Therapeutics Market Size by Application (2016-2027)
7.4 Europe Joint Disease Therapeutics Market Size by Country
7.4.1 Europe Joint Disease Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Joint Disease Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Joint Disease Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Joint Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Joint Disease Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Joint Disease Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Joint Disease Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Joint Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Joint Disease Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Joint Disease Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Joint Disease Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Joint Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Joint Disease Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Joint Disease Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Joint Disease Therapeutics Market Size (2016-2027)
9.2 Latin America Joint Disease Therapeutics Market Size by Type
9.2.1 Latin America Joint Disease Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Joint Disease Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Joint Disease Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Joint Disease Therapeutics Market Size by Application
9.3.1 Latin America Joint Disease Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Joint Disease Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Joint Disease Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Joint Disease Therapeutics Market Size by Country
9.4.1 Latin America Joint Disease Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Joint Disease Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Joint Disease Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Joint Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Joint Disease Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Joint Disease Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Joint Disease Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Joint Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Joint Disease Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Joint Disease Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Joint Disease Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Joint Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Joint Disease Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Joint Disease Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Joint Disease Therapeutics Introduction
11.1.4 AbbVie Revenue in Joint Disease Therapeutics Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Joint Disease Therapeutics Introduction
11.2.4 Pfizer Revenue in Joint Disease Therapeutics Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Joint Disease Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Revenue in Joint Disease Therapeutics Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Joint Disease Therapeutics Introduction
11.4.4 Roche Revenue in Joint Disease Therapeutics Business (2016-2021)
11.4.5 Roche Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Joint Disease Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Joint Disease Therapeutics Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Joint Disease Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Joint Disease Therapeutics Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Astellas Pharma
11.7.1 Astellas Pharma Company Details
11.7.2 Astellas Pharma Business Overview
11.7.3 Astellas Pharma Joint Disease Therapeutics Introduction
11.7.4 Astellas Pharma Revenue in Joint Disease Therapeutics Business (2016-2021)
11.7.5 Astellas Pharma Recent Development
11.8 Johnson&Johnson
11.8.1 Johnson&Johnson Company Details
11.8.2 Johnson&Johnson Business Overview
11.8.3 Johnson&Johnson Joint Disease Therapeutics Introduction
11.8.4 Johnson&Johnson Revenue in Joint Disease Therapeutics Business (2016-2021)
11.8.5 Johnson&Johnson Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Joint Disease Therapeutics Introduction
11.9.4 Amgen Revenue in Joint Disease Therapeutics Business (2016-2021)
11.9.5 Amgen Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Joint Disease Therapeutics Introduction
11.10.4 Novartis Revenue in Joint Disease Therapeutics Business (2016-2021)
11.10.5 Novartis Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Joint Disease Therapeutics Introduction
11.11.4 Sanofi Revenue in Joint Disease Therapeutics Business (2016-2021)
11.11.5 Sanofi Recent Development
11.12 Daiiachi Sankyo
11.12.1 Daiiachi Sankyo Company Details
11.12.2 Daiiachi Sankyo Business Overview
11.12.3 Daiiachi Sankyo Joint Disease Therapeutics Introduction
11.12.4 Daiiachi Sankyo Revenue in Joint Disease Therapeutics Business (2016-2021)
11.12.5 Daiiachi Sankyo Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Joint Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug Therapy
Table 3. Key Players of Rehabilitation
Table 4. Key Players of Surgical Operation
Table 5. Global Joint Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Joint Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Joint Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Joint Disease Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Joint Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Joint Disease Therapeutics Market Share by Regions (2022-2027)
Table 11. Joint Disease Therapeutics Market Trends
Table 12. Joint Disease Therapeutics Market Drivers
Table 13. Joint Disease Therapeutics Market Challenges
Table 14. Joint Disease Therapeutics Market Restraints
Table 15. Global Joint Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Joint Disease Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Joint Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Joint Disease Therapeutics as of 2020)
Table 18. Ranking of Global Top Joint Disease Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Joint Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Joint Disease Therapeutics Product Solution and Service
Table 22. Date of Enter into Joint Disease Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Joint Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Joint Disease Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Joint Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Joint Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Joint Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Joint Disease Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Joint Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Joint Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Joint Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Joint Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Joint Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Joint Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Joint Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Joint Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Joint Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Joint Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Joint Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Joint Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Joint Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Joint Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Joint Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Joint Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Joint Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Joint Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Joint Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Joint Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Joint Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Joint Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Joint Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Joint Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Joint Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Joint Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Joint Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Joint Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Joint Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Joint Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Joint Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Joint Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. AbbVie Company Details
Table 63. AbbVie Business Overview
Table 64. AbbVie Joint Disease Therapeutics Product
Table 65. AbbVie Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 66. AbbVie Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Joint Disease Therapeutics Product
Table 70. Pfizer Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Bristol-Myers Squibb Company Details
Table 73. Bristol-Myers Squibb Business Overview
Table 74. Bristol-Myers Squibb Joint Disease Therapeutics Product
Table 75. Bristol-Myers Squibb Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Bristol-Myers Squibb Recent Development
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Joint Disease Therapeutics Product
Table 80. Roche Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Roche Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Joint Disease Therapeutics Product
Table 85. GlaxoSmithKline Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Joint Disease Therapeutics Product
Table 90. AstraZeneca Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Astellas Pharma Company Details
Table 93. Astellas Pharma Business Overview
Table 94. Astellas Pharma Joint Disease Therapeutics Product
Table 95. Astellas Pharma Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Astellas Pharma Recent Development
Table 97. Johnson&Johnson Company Details
Table 98. Johnson&Johnson Business Overview
Table 99. Johnson&Johnson Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Johnson&Johnson Recent Development
Table 101. Amgen Company Details
Table 102. Amgen Business Overview
Table 103. Amgen Joint Disease Therapeutics Product
Table 104. Amgen Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Amgen Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Joint Disease Therapeutics Product
Table 109. Novartis Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Sanofi Company Details
Table 112. Sanofi Business Overview
Table 113. Sanofi Joint Disease Therapeutics Product
Table 114. Sanofi Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Sanofi Recent Development
Table 116. Daiiachi Sankyo Company Details
Table 117. Daiiachi Sankyo Business Overview
Table 118. Daiiachi Sankyo Joint Disease Therapeutics Product
Table 119. Daiiachi Sankyo Revenue in Joint Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 120. Daiiachi Sankyo Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Joint Disease Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Drug Therapy Features
Figure 3. Rehabilitation Features
Figure 4. Surgical Operation Features
Figure 5. Global Joint Disease Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Joint Disease Therapeutics Report Years Considered
Figure 10. Global Joint Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Joint Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Joint Disease Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Joint Disease Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Joint Disease Therapeutics Market Share by Players in 2020
Figure 15. Global Top Joint Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Joint Disease Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Joint Disease Therapeutics Revenue in 2020
Figure 17. Global Joint Disease Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Joint Disease Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Joint Disease Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Joint Disease Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Joint Disease Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Joint Disease Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Joint Disease Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Joint Disease Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Joint Disease Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Joint Disease Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Joint Disease Therapeutics Market Share by Region (2016-2027)
Figure 39. China Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Joint Disease Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Joint Disease Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Joint Disease Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Joint Disease Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Joint Disease Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Joint Disease Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Joint Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AbbVie Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 64. Astellas Pharma Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 65. Johnson&Johnson Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 66. Amgen Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 68. Sanofi Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 69. Daiiachi Sankyo Revenue Growth Rate in Joint Disease Therapeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
関節疾患治療のグローバル市場：規模・現状・予測2019-2025 Joint disease is defined as any type of injury or inflammation or disease that affects the joints of the body. Joint disease can range from acute to very chronic, excruciatingly painful or simply nagging and uncomfortable.In 2018, the global Joint Disease Therapeutics market size was xx million US$ …- 関節疾患治療のグローバル市場：規模・現状・予測2019-2025 Joint disease is defined as any type of injury or inflammation or disease that affects the joints of the body. Joint disease can range from acute to very chronic, excruciatingly painful or simply nagging and uncomfortable.In 2018, the global Joint Disease Therapeutics market size was xx million US$ …
- 関節疾患治療のグローバル市場：規模・現状・予測2019-2025 Joint disease is defined as any type of injury or inflammation or disease that affects the joints of the body. Joint disease can range from acute to very chronic, excruciatingly painful or simply nagging and uncomfortable.In 2018, the global Joint Disease Therapeutics market size was xx million US$ …
- 世界のAPOL1関与腎臓病市場規模・現状・予測（2021年-2027年） APOL1 gene is a member of APOL gene family, which plays an important role in innate immunity, which is our body’s built-in defense system to fight threats. Some variations in APOL1 gene cause damage to parts within the kidney. Damage to parts that filter blood can lead to severe kidney disease or ul…
- 世界の甲状腺眼症治療市場規模・現状・予測（2021年-2027年） Thyroid eye disease is the inflammation of the eye muscles, eyelids, tear glands and fatty tissues behind the eye. The inflammation leads to swelling of the eye, eyes and eyelids become red and eye ca be pushed forward. The movement of the eye also affects, as both eyes do not move in sync which may…